NCT01892891View on ClinicalTrials.gov

Safety Study of VBY-036 in Healthy Volunteers After 7 Days of Oral Dosing

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Healthy
Interventions
DRUG

VBY-036

Cathepsin S inhibitor

Trial Locations (1)

47710

Covance Evansville, Evansville

All Listed Sponsors
lead

Virobay Inc.

INDUSTRY

NCT01892891 - Safety Study of VBY-036 in Healthy Volunteers After 7 Days of Oral Dosing | Biotech Hunter | Biotech Hunter